| 2023-12-14 | Liquidia Corporation LQDA | director | 279,330 0.4244% | $7.16 | $2M | +83.61% | ||
| 2023-11-17 | Taysha Gene Therapies, Inc. TSHA | 10 percent owner | 100,000 0.0519% | $1.63 | $163,000 | +42.52% | ||
| 2023-08-16 | Taysha Gene Therapies, Inc. TSHA | 10 percent owner | 16.47M 11.9647% | $0.90 | $14.82M | +24.35% | ||
| 2023-07-24 | Verrica Pharmaceuticals Inc. VRCA | 200,000 0.4567% | $5.02 | $1M | +3.13% | |||
| 2022-10-31 | Taysha Gene Therapies, Inc. TSHA | director | 1.5M 3.9684% | $2.00 | $3M | -34.88% | ||
| 2022-07-05 | Verrica Pharmaceuticals Inc. VRCA | 4.76M 9.9243% | $2.10 | $10M | +61.6% | |||
| 2022-04-18 | Liquidia Corporation LQDA | 392,156 0.6258% | $5.10 | $2M | +9.53% | |||
| 2022-02-03 | Taysha Gene Therapies, Inc. TSHA | 76,602 0.2022% | $7.84 | $600,560 | -59% | |||
| 2022-02-02 | Taysha Gene Therapies, Inc. TSHA | 125,000 0.3321% | $7.77 | $971,250 | -57.83% | |||
| 2021-12-03 | Verrica Pharmaceuticals Inc. VRCA | 19,977 0.0723% | $9.22 | $184,188 | -57.78% | |||
| 2021-12-02 | Verrica Pharmaceuticals Inc. VRCA | 30,023 0.1097% | $9.45 | $283,717 | -58.35% | |||
| 2021-11-24 | Taysha Gene Therapies, Inc. TSHA | 2,202 0.0057% | $13.19 | $29,044 | -68.09% | |||
| 2021-11-23 | Taysha Gene Therapies, Inc. TSHA | 20,000 0.0513% | $12.54 | $250,800 | -66.71% | |||
| 2021-07-29 | Candel Therapeutics, Inc. CADL | 1.63M 7.6346% | $8.00 | $13M | -24.18% | |||
| 2021-07-27 | Candel Therapeutics, Inc. CADL | director | 36,000 0.1622% | $7.36 | $264,834 | -18.36% | ||
| 2021-07-06 | Acumen Pharmaceuticals, Inc. ABOS | 10 percent owner | 312,500 0.6468% | $16.00 | $5M | -67.95% | ||
| 2021-05-14 | Taysha Gene Therapies, Inc. TSHA | 12,000 0.0321% | $20.98 | $251,760 | -28.44% | |||
| 2021-04-13 | Liquidia Corporation LQDA | 396,826 0.7682% | $2.52 | $1M | +23.24% | |||
| 2021-03-25 | Verrica Pharmaceuticals Inc. VRCA | 739,830 3.134% | $14.75 | $10.91M | -18.82% | |||
| 2020-08-20 | Verrica Pharmaceuticals Inc. VRCA | 20,000 0.0784% | $9.09 | $181,800 | +19.61% |